Literature DB >> 10595919

Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas.

H P Kourea1, C Cordon-Cardo, M Dudas, D Leung, J M Woodruff.   

Abstract

There is little information regarding the status of cell cycle regulators in malignant peripheral nerve sheath tumors (MPNSTs) and neurofibromas (NFs). In this study, we investigated patterns of expression of p53 and pRB, cyclin-dependent kinase inhibitors (CKIs) p21 and p27, as well as cyclins D1 and E, in a cohort of 35 well-characterized MPNSTs and 16 NFs. These phenotypes were correlated with proliferative index, as assessed by Ki-67, as well as clinicopathological parameters of poor outcome. p53 nuclear overexpression was found in 10 of 35 (29%) MPNSTs, and it was lacking in NFs (P = 0.02). There were no differences in the patterns of expression of pRB, cyclin D1, and p21 between MPNSTs and NFs. However, p27 nuclear expression was present in most NFs, but it was absent in the majority of MPNSTs, which displayed cytoplasmic staining (P < 0.001). Nuclear cyclin E expression was more pronounced in MPNSTs than in NFs. We observed inverse patterns of expression for nuclear p27 and nuclear cyclin E expression. The staining profiles of cytoplasmic p27 and nuclear cyclin E expression were found to be statistically associated (P = 0.01). High Ki-67 expression was found in 20 of 34 (59%) MPNSTs but was absent in NFs (P < 0.001). Furthermore, detection of cytoplasmic p27 expression was found to be a prognostic factor for poor survival in MPNSTs (P = 0.03, relative risk = 2.4).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595919      PMCID: PMC1866917          DOI: 10.1016/S0002-9440(10)65508-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  Regulation of cyclin E transcription by E2Fs and retinoblastoma protein.

Authors:  Y Geng; E N Eaton; M Picón; J M Roberts; A S Lundberg; A Gifford; C Sardet; R A Weinberg
Journal:  Oncogene       Date:  1996-03-21       Impact factor: 9.867

2.  Cyclin E-CDK2 is a regulator of p27Kip1.

Authors:  R J Sheaff; M Groudine; M Gordon; J M Roberts; B E Clurman
Journal:  Genes Dev       Date:  1997-06-01       Impact factor: 11.361

Review 3.  Role of the cyclin-dependent kinase inhibitors in the development of cancer.

Authors:  T Hirama; H P Koeffler
Journal:  Blood       Date:  1995-08-01       Impact factor: 22.113

4.  p53 expression in neurofibroma and malignant peripheral nerve sheath tumor. An immunohistochemical study of sporadic and NF1-associated tumors.

Authors:  K C Halling; B W Scheithauer; A C Halling; A G Nascimento; S C Ziesmer; P C Roche; P C Wollan
Journal:  Am J Clin Pathol       Date:  1996-09       Impact factor: 2.493

5.  Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours.

Authors:  L G Kindblom; M Ahldén; J M Meis-Kindblom; G Stenman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4.

Authors:  F K Chan; J Zhang; L Cheng; D N Shapiro; A Winoto
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

7.  Human cyclin E, a nuclear protein essential for the G1-to-S phase transition.

Authors:  M Ohtsubo; A M Theodoras; J Schumacher; J M Roberts; M Pagano
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

Review 8.  Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.

Authors:  C Cordon-Cardo
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

9.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

Authors:  M Pagano; S W Tam; A M Theodoras; P Beer-Romero; G Del Sal; V Chau; P R Yew; G F Draetta; M Rolfe
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

10.  Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas.

Authors:  M S Karpeh; M F Brennan; W G Cance; J M Woodruff; D Pollack; E S Casper; M E Dudas; E Latres; M Drobnjak; C Cordon-Cardo
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

View more
  28 in total

Review 1.  Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems.

Authors:  Fausto J Rodriguez; Andrew L Folpe; Caterina Giannini; Arie Perry
Journal:  Acta Neuropathol       Date:  2012-02-12       Impact factor: 17.088

2.  Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas.

Authors:  H P Kourea; I Orlow; B W Scheithauer; C Cordon-Cardo; J M Woodruff
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors.

Authors:  Christian Hagel; Ulrich Zils; Matthias Peiper; Lan Kluwe; Stefan Gotthard; Reinhard E Friedrich; David Zurakowski; Andreas von Deimling; Victor Felix Mautner
Journal:  J Neurooncol       Date:  2006-11-17       Impact factor: 4.130

4.  Transcriptional profiling in an MPNST-derived cell line and normal human Schwann cells.

Authors:  Philip R Lee; Jonathan E Cohen; Elisabetta A Tendi; Robert Farrer; George H DE Vries; Kevin G Becker; R Douglas Fields
Journal:  Neuron Glia Biol       Date:  2004-05

Review 5.  Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.

Authors:  Brigitte C Widemann
Journal:  Curr Oncol Rep       Date:  2009-07       Impact factor: 5.075

Review 6.  Molecular targets for NF1-associated malignant peripheral nerve sheath tumor.

Authors:  Lama Binobaid; Michal M Masternak
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-27

7.  Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.

Authors:  Syed J Kazmi; Stephanie J Byer; Jenell M Eckert; Amy N Turk; Richard P H Huijbregts; Nicole M Brossier; William E Grizzle; Fady M Mikhail; Kevin A Roth; Steven L Carroll
Journal:  Am J Pathol       Date:  2013-01-13       Impact factor: 4.307

8.  Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.

Authors:  Adrienne L Watson; Eric P Rahrmann; Branden S Moriarity; Kwangmin Choi; Caitlin B Conboy; Andrew D Greeley; Amanda L Halfond; Leah K Anderson; Brian R Wahl; Vincent W Keng; Anthony E Rizzardi; Colleen L Forster; Margaret H Collins; Aaron L Sarver; Margaret R Wallace; Stephen C Schmechel; Nancy Ratner; David A Largaespada
Journal:  Cancer Discov       Date:  2013-03-27       Impact factor: 39.397

9.  Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors.

Authors:  Helge R Brekke; Matthias Kolberg; Rolf I Skotheim; Kirsten S Hall; Bodil Bjerkehagen; Björn Risberg; Henryk A Domanski; Nils Mandahl; Knut Liestøl; Sigbjørn Smeland; Håvard E Danielsen; Fredrik Mertens; Ragnhild A Lothe
Journal:  Neuro Oncol       Date:  2009-01-30       Impact factor: 12.300

10.  Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis.

Authors:  Stephanie N Brosius; Amy N Turk; Stephanie J Byer; Nicole M Brossier; Latika Kohli; Amber Whitmire; Fady M Mikhail; Kevin A Roth; Steven L Carroll
Journal:  Acta Neuropathol       Date:  2014-04       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.